期刊文献+

肾素-血管紧张素系统拮抗剂用于治疗射血分数保留的心力衰竭尚缺乏明确的证据

原文传递
导出
摘要 背景 射血分数保留的心力衰竭(HFpEF)患者约占整个社会心力衰竭患者人数的二分之一。这与心力衰竭的高发病率与病死率密切相关,然而目前并未证实有药物能有效降低此类患者的病死率。
出处 《英国医学杂志中文版》 2014年第1期53-54,共2页 The BMJ Chinese Edition
  • 相关文献

参考文献6

  • 1Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am. Call Cardiel 2004;43:317-27.
  • 2Borlaug BA, Redfield MM. Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation. 2011 ; 123 :2006-13.
  • 3De KeuJenaer GW, Brutsaert DL Systolic and diastolic heart failure are overlapping phenotypes within the heart failure spectrum. Circuloiioa 2011; 123: 1996-2004.
  • 4Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003; 362: 777-81.
  • 5Massie BM, Carson PE, McMurray JJ, et 81. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008; 359: 2456-67.
  • 6Cleland JG, Tendera M, Adamus J, et al, The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006;27 :233845.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部